Robert M. Califf

As many as sixteen bipartisan congressional lawmakers signed a letter Thursday urging the Biden administration to make marijuana scheduling review available to the public. There is no doubt that cannabis scheduling will be a burning topic among many other issues at the...

The Food and Drug Administration has determined that certain naloxone products like Narcan are safe enough to potentially be sold without a prescription. Narcan, a brand name for naloxone, is a medication used to reverse the effects of opioids, usually in the case of an...

The FDA's Science Board has once again reviewed the idea of incorporating cannabinoids into dietary supplements. At a Tuesday meeting with the FDA's public advisory committee, the panel focused on “challenges in evaluating the safety of dietary supplement and food...

FDA To Review CBD Once Again The U.S. Food and Drug Administration’s Science Board is expected to review the idea of incorporating cannabinoids into dietary supplements on Tuesday at the public advisory committee meeting. However, broad market sentiment is not that optimistic that the virtual...

FDA Chief Recognizes Slow Progress On CBD Regulations   Dr. Robert M. Califf confirmed on Thursday at a congressional panel that the FDA has made little progress on the regulatory framework around CBD products over the years since Trump signed the Farm Bill in late 2018.  ...

President Joe Biden is nominating former U.S. Food and Drug Administration Commissioner Robert M. Califf, to lead the agency, once again. Califf, 70, a  cardiologist and clinical trial specialist, served as FDA commissioner for the last 11 months of President Barack Obama’...